Literature DB >> 11054022

Increased expression of protease M in ovarian tumors.

H Tanimoto1, L J Underwood, K Shigemasa, T H Parmley, T J O'Brien.   

Abstract

Proteases are known to play important roles in tumor invasion and metastasis. Protease M, which was originally identified by Anisowicz and colleagues in 1996, is a new member of the serine protease family. We also identified the protease M transcript in a differential PCR screen of ovarian tumors and have investigated its expression in 44 ovarian tumors (12 low malignant potential tumors, 32 carcinomas) and 10 normal ovaries using quantitative PCR. The PCR product was labeled with (32)P and a phosphoimager was used to determine the relative expression of the protease M gene compared to internal control beta-tubulin. mRNA expression levels of protease M were significantly elevated in 9 of 12 low malignant potential tumors and 30 of 32 carcinomas. Northern blot hybridization showed that the 1.7-kb protease M transcript was abundant in carcinoma but not detected in normal ovary. Immunohistochemical staining of normal ovary and ovarian tumor tissue sections with antibodies generated to protease M derived peptides corroborated the semi-quantitative PCR and Northern analysis data. Our results suggest that protease M is frequently overexpressed in ovarian tumors and may therefore contribute to the invasive nature or growth capacity of ovarian carcinomas. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11054022     DOI: 10.1159/000030150

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

1.  Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.

Authors:  Jin Ju Kim; Jong-Tae Kim; Hyo Ran Yoon; Min Ah Kang; Joo Heon Kim; Young-Ha Lee; Jae Wha Kim; Seon-Jin Lee; Eun Young Song; Pyung Keun Myung; Hee Gu Lee
Journal:  Tumour Biol       Date:  2012-02-29

Review 2.  Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwendlyn Kollmorgen; Rüdiger Rueger
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

3.  Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.

Authors:  Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos
Journal:  Tumour Biol       Date:  2014-01-16

4.  Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.

Authors:  Yiwei Li; Mingxin Che; Sunita Bhagat; Kerrie-Lynn Ellis; Omer Kucuk; Daniel R Doerge; Judith Abrams; Michael L Cher; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

5.  Over-expression of human kallikrein 11 is associated with poor prognosis in patients with low rectal carcinoma.

Authors:  Xiao Yu; Hua Yong Tang; Xiao Rong Li; Xiao Wen He; Kai Min Xiang
Journal:  Med Oncol       Date:  2009-01-29       Impact factor: 3.064

6.  Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.

Authors:  N M A White; T-F F Chow; S Mejia-Guerrero; M Diamandis; Y Rofael; H Faragalla; M Mankaruous; M Gabril; A Girgis; G M Yousef
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

7.  Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system.

Authors:  Uros Kuzmanov; Nianxin Jiang; Christopher R Smith; Antoninus Soosaipillai; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2008-12-16       Impact factor: 5.911

8.  Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer.

Authors:  H Tanimoto; K Shigemasa; X Tian; L Gu; J B Beard; T Sawasaki; T J O'Brien
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

9.  KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.

Authors:  N M A White; M Mathews; G M Yousef; A Prizada; C Popadiuk; J J E Doré
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

10.  Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.

Authors:  B R Hoffman; D Katsaros; A Scorilas; P Diamandis; S Fracchioli; I A Rigault de la Longrais; T Colgan; M Puopolo; G Giardina; M Massobrio; E P Diamandis
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.